Association of neovascular age-related macular degeneration and hyperhomocysteinemia

By Axer-Siegel R.   Bourla D.   Ehrlich R.   Dotan G.   Benjamini Y.   Gavendo S.   Weinberger D.   Sela B.-A.  

American Journal of Ophthalmology, Vol. 137, Iss. 1, 2004-01 ,pp. : 84-89

Elsevier

Access to resources Recommend Favorite

Bevacizumab versus ranibizumab in the treatment of exudative age-related macular degeneration

By Gamulescu Maria-Andreea   Radeck Viola   Lustinger Bruno   Fink Bianca   Helbig Horst  

International Ophthalmology, Vol. 30, Iss. 3, 2010-06 ,pp. : 261-266

Springer Publishing Company

Access to resources Recommend Favorite

Subconjunctival Palomid 529 in the treatment of neovascular age-related macular degeneration

By Dalal Monica   Jacobs-El Naima   Nicholson Benjamin   Tuo Jingsheng   Chew Emily   Chan Chi-Chao   Nussenblatt Robert   Ferris Frederick   Meyerle Catherine  

Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 251, Iss. 12, 2013-12 ,pp. : 2705-2709

Springer Publishing Company

Access to resources Recommend Favorite

Intravitreal bevacizumab for pigment epithelial detachments in age-related macular degeneration

By Hamelmann Victoria   Helb Hans -Martin   Meyer Carsten H.   Holz Frank G.   Eter Nicole  

Spektrum der Augenheilkunde, Vol. 27, Iss. 4, 2013-08 ,pp. : 184-195

Springer Publishing Company

Access to resources Recommend Favorite

Prevention of age-related macular degeneration

By Wong Ian  

International Ophthalmology, Vol. 31, Iss. 1, 2011-02 ,pp. : 73-82

Springer Publishing Company

Access to resources Recommend Favorite